Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5541 Target Snapshot

Histone deacetylase · SINGLE PROTEIN · Plasmodium falciparum

34Compounds
6Assays
4Approved Drugs
34.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9XYC7. Use UniProt Q9XYC7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9XYC7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone deacetylase as ChEMBL target CHEMBL5541, mapped to UniProt Q9XYC7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone deacetylase
SINGLE PROTEIN · Plasmodium falciparum
As of 2026-09-13
ChEMBL target ID
CHEMBL5541
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9XYC7
Histone deacetylase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone deacetylase is the right protein anchor across sources, using UniProt Q9XYC7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone deacetylase
UniProt AccessionQ9XYC7
Component TypeProtein
Sequence Length449 aa

Histone deacetylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone deacetylase, mapped to UniProt Q9XYC7. Sequence length is 449 aa.

Mapped IDQ9XYC7
Review nameHistone deacetylase
OrganismPlasmodium falciparum
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase III
1
Phase I
Assay Mix

Activity Type Distribution

IC5034.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL99 9.22 IC50 0.6 Preclinical
CHEMBL343448 9.05 IC50 0.9 Approved
CHEMBL430060 9.0 IC50 1.0 Preclinical
CHEMBL483254 8.74 IC50 1.8 Approved
CHEMBL1214760 8.0 IC50 10.0 Preclinical
CHEMBL490032 7.82 IC50 15.0 Preclinical
CHEMBL519035 7.7 IC50 20.0 Preclinical
CHEMBL490229 7.66 IC50 22.0 Preclinical
CHEMBL506834 7.54 IC50 29.0 Preclinical
CHEMBL307765 7.44 IC50 36.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
2
6.0
6
6.5
15
7.0
4
7.5
2
8.0
1
8.5
3
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PANOBINOSTAT
CHEMBL483254
Approved 2015
BELINOSTAT
CHEMBL408513
Approved 2014
ROMIDEPSIN
CHEMBL343448
Approved 2009
VORINOSTAT
CHEMBL98
Approved 2006
Assay Landscape

Assay Landscape

6
Total Assays
33
Tested Compounds
1
Assay Types
Binding — 6 assays, 33 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 11 7.4
cell-based format 2 22 7.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine